Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal Biosciences Investor Briefing, Sydney 13 July 2015

Opal Biosciences Investor Briefing, Sydney 13 July 2015 July 7, 2015 • Category • Author Name

Opal Biosciences Investor Briefing, Sydney 13 July 2015

Latest News

Notice of Meeting and Proxy Form

March 26, 2024

Notice of General Meeting on Friday, 19 April 2024 at 2.00pm (Melbourne time) read the full announcement.

Read More
CEO AGM 2023 Presentation

November 30, 2023

View the CEO AGM 2023 Presentation

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions